NCT02316327View on ClinicalTrials.gov

Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

October 31, 2016

Conditions
Non-Small Cell Lung Cancer (NSCLC)
Interventions
DRUG

gemcitabine, cisplatin and bevacizumab

Therapeutic

Trial Locations (1)

08036

Hospital Clinic, Barcelona

All Listed Sponsors
lead

Fundacion Clinic per a la Recerca Biomédica

OTHER

NCT02316327 - Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab | Biotech Hunter | Biotech Hunter